Diego Useche
Names
| first: | Diego |
| last: | Useche |
Identifer
| RePEc Short-ID: | pus30 |
Contact
Affiliations
-
Université de Rennes 1
/ Faculté des Sciences Économiques
- EDIRC entry
- location:
Research profile
author of:
- Are patents signals for the IPO market? An EU–US comparison for the software industry (RePEc:eee:respol:v:43:y:2014:i:8:p:1299-1311)
by Useche, Diego - Are patents signals for the IPO market? An EU–US comparison for the software industry (RePEc:hal:journl:hal-01135634)
by Diego Useche - Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies (RePEc:hal:journl:hal-02195744)
by Diego Useche & Philippe Gorry - Empirical economic analysis of orphan drug legislation impact on innovation (RePEc:hal:journl:hal-02195798)
by Philippe Gorry & Diego Useche & Martin Zumpe - Empirical Economic Analysis of Orphan Drug Innovation (RePEc:hal:journl:hal-02195829)
by Philippe Gorry & Diego Useche & Martin Zumpe - Empirical Economic Analysis of Orphan Drug Innovation (RePEc:hal:journl:hal-02195838)
by Philippe Gorry & Cyril Benoît & Diego Useche & Martin Zumpe - Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies (RePEc:hal:journl:hal-02195963)
by Diego Useche & Philippe Gorry - Highly-skilled migrants and Cross-border M&A: Firm-level evidence (RePEc:hal:journl:hal-02271307)
by F. Lissoni & D. Useche & E. Miguelez - Empirical Economic Analysis of Orphan Drug Innovation (RePEc:hal:journl:hal-02273799)
by Philippe Gorry & Cyril Benoît & Diego Useche & Martin Zumpe - Empirical Economic Analysis of Orphan Drug Legislation Impact on Innovation (RePEc:hal:journl:hal-02273805)
by Philippe Gorry & Diego Useche & Martin Zumpe - Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms (RePEc:hal:journl:hal-02797121)
by Diego Useche & Sophie Pommet - Highly skilled and well connected: Migrant inventors in cross-border M&As (RePEc:hal:journl:hal-03097926)
by Diego Useche & Ernest Miguelez & Francesco Lissoni - Highly-skilled migrants and Cross-border M&A: Firm-level evidence (RePEc:hal:journl:hal-03145889)
by Diego Useche & Ernest Miguelez & Francesco Lissoni - Highly-skilled migrants and Cross-border M&A: Firm-level evidence (RePEc:hal:journl:hal-03145936)
by Diego Useche & Ernest Miguelez & Francesco Lissoni - Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital (RePEc:hal:journl:hal-03593089)
by Vincenzo Butticè & Diego Useche - Highly-skilled migrants and Cross-border M&A: Firm-level evidence (RePEc:hal:journl:halshs-02024499)
by Diego Useche & Ernest Miguelez & Francesco Lissoni - Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021 (RePEc:hal:wpaper:hal-02152419)
by Philippe Gorry & Diego Useche - Highly skilled and well connected: Migrant inventors in cross-border M&As (RePEc:hal:wpaper:hal-03118061)
by D. Useche & Ernest Miguelez & Francesco Lissoni - Highly skilled and well connected: Migrant inventors in cross-border M&As (RePEc:hal:wpaper:hal-03125216)
by D. Useche & Ernest Miguelez & Francesco Lissoni - Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms (RePEc:kap:sbusec:v:57:y:2021:i:3:d:10.1007_s11187-020-00351-x)
by Diego Useche & Sophie Pommet - Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital (RePEc:kap:sbusec:v:59:y:2022:i:4:d:10.1007_s11187-021-00591-5)
by Vincenzo Butticè & Diego Useche - Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies (RePEc:nbr:nberch:13995)
by Philippe Gorry & Diego Useche - Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies (RePEc:nbr:nberwo:24021)
by Philippe Gorry & Diego Useche - Highly skilled and well connected: Migrant inventors in cross-border M&As (RePEc:pal:jintbs:v:51:y:2020:i:5:d:10.1057_s41267-018-0203-3)
by Diego Useche & Ernest Miguelez & Francesco Lissoni - Patenting Behaviour and the Survival of Newly Listed European Software Firms (RePEc:taf:indinn:v:22:y:2015:i:1:p:37-58)
by Diego Useche